Sunday, January 23, 2022

Oral penicillin, not injectable, advised for people with high-risk rheumatic heart disease

 

https://www.eurekalert.org/news-releases/940497


 News Release 20-Jan-2022
American Heart Association Presidential Advisory
Peer-Reviewed Publication
American Heart Association

 

A growing body of evidence indicates that some people thought to have an allergic response to injectable penicillin, the standard treatment for rheumatic heart disease, may instead be experiencing a cardiac reaction to the medicine, according to a new American Heart Association presidential advisory published today in Journal of the American Heart Association. The advisory, which represents official insights from the American Heart Association, suggests oral penicillin may be a safer option for people with rheumatic heart disease who are at high risk of a cardiac reaction.

-----

 



No comments:

Post a Comment